Internal Med

Your Article Summary

See Latest Articles

Caspofungin for the treatment of candidaemia in patients with haematological malignancies
Clinical Microbiology and Infection, 06/29/09

Pagano L et al. - In a study to evaluate the efficacy of caspofungin in neutropenic pts with haematological malignancies (HM) and candidaemia, results suggest that treatment of candidaemia with caspofungin in neutropenic HM was efficacious, as it is in non-haematological subgroups.

• This study was prospectively conducted in 11 haematology divisions over a 2-yr period to evaluate the efficacy of caspofungin in 24 neutropenic pts with haematological malignancies (HM) and candidaemia.

• Pts had received chemotherapy for HM and were neutropenic (PNN < 0.5 x 109/L) for a median of 12 days (2–41) before candidaemia.
• Pts received caspofungin for a median duration of 12 days, obtaining a favourable overall response of 58%.
• At 30 days, 11 pts had died (46%); candidaemia was responsible for mortality in 6 pts (25%).

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09

New Anticoagulants in Atrial Fibrillation
Seminars in Thrombosis and Hemostasis, 10/02/09

Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy , 10/20/09

See All of Clinical Pharmacology

Today in Infectious Disease...keeping you current

Receive free subspecialty "5-minute updates" via email

Statins for the Prevention and Treatment of Infections
Archives of Internal Medicine, 10/13/09

Interventions for HIV-associated nephropathy
Cochrane Reviews, 10/20/09

Acyclovir: a new use for an old drug
Current Opinion in Infectious Diseases, 10/28/09

See All of Infectious Disease